다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.30 no.1, 1999년, pp.156 - 160
Chariot, Patrick (Patrick Chariot, Dé) , Drogou, Irène (partement de Pathologie, Hô) , Lacroix-Szmania, Isabelle de (pital Henri Mondor, 94010 Cré) , Eliezer-Vanerot, Marie-Christine (teil, France. Tel: 00 33 1 49 81 27 34. Fax: 00 33 1 49 81 27 33.) , Chazaud, Bénédicte (Groupe d'Etudes et de Recherches sur le Muscle et le Nerf (EA 2347, Université) , Lombès, Anne (Paris XII), Faculté) , Schaeffer, Annette (de Mé) , Zafrani, Elie Serge (decine, Cré)
AI-Helper
AbstractZidovudine is known to be responsible for a mitochondrial myopathy with ragged-red fibres and mitochondrial DNA depletion in muscle. Lactic acidosis alone or associated with hepatic abnormalities has also been reported. A single report mentioned the concomitant occurrence of muscular and hep...
Lancet 348 283 1996 10.1016/S0140-6736(96)05387-1 The Delta Coordinating Committee: Delta: a randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
AIDS Hammer 10 suppl 3 S1 1996 Advances in an antiretroviral therapy and viral load monitoring
N Engl J Med Yarchoan 321 726 1989 10.1056/NEJM198909143211106 Clinical pharmacology of 3′-azido-2′3′-dideoxythymidine (zidovudine) and related dideoxynucleosides
Nat Med Lewis 1 417 1995 10.1038/nm0595-417 Mitochondrial toxicity of antiviral drugs
Mol Pharmacol Chen 39 625 1991 Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity
Ann Intern Med Lai 115 283 1991 10.7326/0003-4819-115-4-283 Fulminant hepatic failure associated with 2′,3′dideoxyinosine (ddI)
J Intern Med Bissuel 235 367 1994 10.1111/j.1365-2796.1994.tb01088.x Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
AIDS Lenzo 11 1294 1997 10.1097/00002030-199710001-00003 Hepatic steatosis and lactic acidosis associated with stavudine trearment in an HIV patient: a case report
N Engl J Med McKenzie 333 1099 1995 10.1056/NEJM199510263331702 Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B infection
Lab Invest Semino-Mora 76 487 1997 Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro
Proc Natl Acad Sci USA Lewis 93 3592 1996 10.1073/pnas.93.8.3592 Fialuridine and its metabolites inhibit DNA polymerase γ at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts
N Engl J Med Dalakas 322 1098 1990 10.1056/NEJM199004193221602 Mitochondrial myopathy caused by long-term zidovudine therapy
Ann Neurol Mhiri 29 606 1991 10.1002/ana.410290607 Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction
Neuromusc Disord Chariot 1 357 1991 10.1016/0960-8966(91)90122-9 Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy
Ital J Neurol Sci Tomelleri 13 723 1992 10.1007/BF02229156 AZT-induced mitochondrial myopathy
Arthritis Rheum Chariot 37 583 1994 10.1002/art.1780370421 Blood lactate/pyruvate ratio as a non invasive test for the diagnosis of zidovudine myopathy
Lancet Arnaudo 337 508 1991 10.1016/0140-6736(91)91294-5 Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
Ann Intern Med Chattha 118 37 1993 10.7326/0003-4819-118-1-199301010-00007 Lactic acidosis complicating the acquired immunodeficiency syndrome
Presse Med Maslo 23 717 1994 Acidose lactique chez des patients infectes par le VIH
AIDS Freiman 7 379 1993 10.1097/00002030-199303000-00012 Hepatomegaly with severe steatosis in HIV-seropositive patients
AIDS Le Bras 8 716 1994 Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?
Clin Infect Dis Olano 21 973 1995 10.1093/clinids/21.4.973 Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine
Ann Intern Med Dubin 110 85 1989 10.7326/0003-4819-110-1-85 Zidovudine-induced hepatotoxicity
J Intern Med Gradon 231 317 1992 10.1111/j.1365-2796.1992.tb00542.x Zidovudine-induced hepatitis
Pathology Chen 24 109 1992 10.3109/00313029209063634 Concurrent zidovudine-induced myopathy and hepatotoxicity in patients treated for HIV infection
Am J Gastroenterol Fortgang 90 1433 1995 Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy
Ann Neurol Chariot 34 561 1993 10.1002/ana.410340409 Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy
J Mol Biol Drouin 140 15 1980 10.1016/0022-2836(80)90354-X Cloning of human mitochondrial DNA in Escherichia coli
Proc Natl Acad Sci USA Gonzalez 82 7666 1985 10.1073/pnas.82.22.7666 Variation among human 28S ribosomal RNA genes
Antimicrob Agents Chemother Canas 40 230 1996 10.1128/AAC.40.1.230 Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus
Lab Lnvest Lamperth 65 742 1991 Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model
Pathol Res Pract Corcuera 192 182 1996 10.1016/S0344-0338(96)80218-4 Hepatic morphological alterations induced by zidovudine in an experimental model
J Neurol Sci Benbrik 149 19 1997 10.1016/S0022-510X(97)05376-8 Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI), and zalcitabine (ddC) on cultured human muscle cells
Hepatology Bioulac-Sage 18 839 1993 10.1002/hep.1840180414 Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency); a light and electron microscopic study of the liver
J Hepatol Fromenty 26 suppl 1 13 1997 10.1016/S0168-8278(97)82328-8 Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation
J Inter Metab Dis Poggi-Travert 19 478 1996 10.1007/BF01799109 Metabolic intermediates in lactic acidosis: compounds, samples and interpretation
Hammans 49 1994 Mitochondrial Disorders in Neurology Mitochondrial myopathies: clinical features, investigation, treatment and genetic counselling
Am J Hum Genet Moraes 48 492 1991 MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases
Brain Casademont 119 1357 1996 10.1093/brain/119.4.1357 The effects of zidovudine on skeletal muscle mt-DNA in HIV-1 infected patients with mild or no muscle dysfunction
Ann Intern Med Herskowitz 116 311 1992 10.7326/0003-4819-116-4-311 Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases
J Inher Metab Dis Munnich 19 521 1996 10.1007/BF01799112 Clinical presentation of mitochondrial disorders in childhood
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.